In partnership with:
This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Effect of everolimus on the pharmacokinetics of octreotide long-acting repeatable in patients with advanced neuroendocrine tumors: An analysis of the randomized phase III RADIANT-2 trial
- ME Pavel, C Becerra, K Grosch, W Cheung, J Hasskarl, JC Yao
- Clinical Pharmacology & Therapeutics, December 2016, Wiley
- DOI: 10.1002/cpt.559